Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × palbociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasm Metastasis 11 Neoplasms 8 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Breast Diseases 4 Sarcoma 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Liposarcoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumors 2 Advanced Breast Cancer 2 von Hippel-Lindau Disease 1 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Venous Thromboembolism 1

Interventions

venetoclax 61 Cyclophosphamide 51 ibrutinib 46 obinutuzumab 42 acalabrutinib 41 Rituximab 40 fludarabine 32 fludarabine phosphate 27 Specimen Handling 25 zanubrutinib 24 pirtobrutinib 23 Biopsy 22 Whole-Body Irradiation 16 Bendamustine Hydrochloride 16 Mycophenolic Acid 13 Magnetic Resonance Spectroscopy 13 Lenalidomide 12 Tacrolimus 8 Sirolimus 7 Peripheral Blood Stem Cell Transplantation 7 idelalisib 6 Prednisone 6 Melphalan 6 CT-P10 6 Busulfan 6 tafasitamab 5 pembrolizumab 5 ofatumumab 5 Stem Cell Transplantation 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡